Literature DB >> 7664889

Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent.

A R Hipkiss1, J Michaelis, P Syrris.   

Abstract

The dipeptide carnosine (beta-alanyl-L-histidine) was readily glycosylated non-enzymatically upon incubation with the sugars glucose, galactose, deoxyribose and the triose dihydroxyacetone. Carnosine inhibited glycation of actyl-Lys-His-amide by dihydroxyacetone and it protected alpha-crystallin, superoxide dismutase and catalise against glycation and cross-linking mediated by ribose, deoxyribose, dihydroxyacetone, dihydroxyacetone phosphate and fructose. Unlike certain glycated amino acids, glycated carnosine was non-mutagenic. The potential biological and therapeutic significance of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664889     DOI: 10.1016/0014-5793(95)00849-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  40 in total

1.  Differential response of embryonic stem cells and teratocarcinoma cells to carnosine.

Authors:  G McFarland; R Holliday
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

Review 2.  Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication.

Authors:  H Younus; S Anwar
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

3.  Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.

Authors:  Margaret-Ann M Nelson; Zachariah J Builta; T Blake Monroe; Jonathan A Doorn; Ethan J Anderson
Journal:  Amino Acids       Date:  2018-09-06       Impact factor: 3.520

4.  New dinitrosyl iron complexes bound with physiologically active dipeptide carnosine.

Authors:  Konstantin B Shumaev; Olga V Kosmachevskaya; Elvira I Nasybullina; Sergey V Gromov; Alexander A Novikov; Alexey F Topunov
Journal:  J Biol Inorg Chem       Date:  2016-11-22       Impact factor: 3.358

Review 5.  Possible Benefit of Dietary Carnosine towards Depressive Disorders.

Authors:  Alan R Hipkiss
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 6.  Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training.

Authors:  Wim Derave; Inge Everaert; Sam Beeckman; Audrey Baguet
Journal:  Sports Med       Date:  2010-03-01       Impact factor: 11.136

7.  Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.

Authors:  Pingyang Liu; Xiaomei Ge; Haizhen Ding; Honglin Jiang; Bruce M Christensen; Jianyong Li
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

8.  Effect of beta-alanine supplementation on the onset of blood lactate accumulation (OBLA) during treadmill running: Pre/post 2 treatment experimental design.

Authors:  Thomas Jordan; Judith Lukaszuk; Mark Misic; Josephine Umoren
Journal:  J Int Soc Sports Nutr       Date:  2010-05-19       Impact factor: 5.150

Review 9.  Glycotoxins: Dietary and Metabolic Origins; Possible Amelioration of Neurotoxicity by Carnosine, with Special Reference to Parkinson's Disease.

Authors:  Alan R Hipkiss
Journal:  Neurotox Res       Date:  2018-02-07       Impact factor: 3.911

10.  Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.

Authors:  Hong Yan; Yong Guo; Jie Zhang; Zhenghua Ding; Wenjing Ha; J J Harding
Journal:  Mol Vis       Date:  2008-12-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.